| Nov. 24/Dec. 1, 2003 | |||||||||
In Print![]() Photo by Steve Gilbert
From Focus: Recent evidence suggests that stem cells may derive some of their potency from an ability to fuse with differentiated cells. Markus Frank and colleagues report that the cell surface protein dubbed ABCB5 is produced in progenitor cells isolated from the skin. These cells not only fuse with more developed cells, but their fusion is promoted by antibodies to ABCB5. So the protein may represent a cell marker for fusion.
|
|
HeadlinesRegeneration of Insulin-producing Islets May Lead to Diabetes Cure
UpcomingDivision of Medical Ethics:Ethical Forecasting Forum A Screening of Bloodlines: Technology Hits Home Panel Discussion: Are We Creating a World that We Won't Want to Inhabit?
Judy Foreman, Boston Globe Debate on "Open Access" Publishing
Multiple presenters |
Spotlight
Student Scene
Lab WorksA multimedia site featuring Harvard Medical research |
||||||
Calendar | Jobs | Harvard Medical School Home | Hospitals | Back Issues | Feedback | Home |